US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Talphera Inc.

0.8026

-0.0064-0.79%

Post-market: 0.80260.00000.00%18:36 EDT

Volume:105.26K

Turnover:85.20K

Market Cap:40.17M

PE:-2.38

High:0.8398

Open:0.7923

Low:0.7900

Close:0.8090

52wk High:1.57

52wk Low:0.3800

Shares:50.05M

Float Shares:25.15M

Volume Ratio:0.98

T/O Rate:0.42%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.3369

EPS(LYR):-0.3383

ROE:-114.74%

ROA:-35.15%

PB:2.36

PE(LYR):-2.37

Loading ...

Overview Company News Filings

Talphera CEO Vincent J. Angotti acquires 213,310 common shares; value rises to $125,000

Talphera announces two abstracts accepted for AKI & CRRT 2026; NEPHRO-CRRT nafamostat registrational study enrolls patients

Analysts Offer Insights on Healthcare Companies: Fennec Pharmaceuticals (FENC), Talphera (TLPH) and Abivax SA Sponsored ADR (ABVX)

Talphera Q4 EPS $(0.06) Beats $(0.14) Estimate

Talphera Q4 net loss widens 101.71% to USD 3.8 million on cash and investments of USD 20 million

Talphera Inc - Expects 2026 Cash Operating Expenses Excluding Stock-Based Compensation of $17 Mln-$18 Mln

THOMSON REUTERS

Talphera, Inc Q4 Net Income From Cont Ops USD -3.772 Million

THOMSON REUTERS

Press Release: Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Talphera to host virtual investor and analyst event on Niyad for CRRT

Talphera sells 639,931 shares in private placement for USD 4.1 million

Nasdaq flags Talphera bid-price noncompliance risk

Analysts’ Opinions Are Mixed on These Healthcare Stocks: CalciMedica (CALC) and Talphera (TLPH)

Talphera to Host Virtual Investor and Analyst Event at 11:00 a.m. ET

BRIEF-Talphera Announces 50% Enrollment Milestone In Ongoing Nephro-Crrt Registrational Trial

Talphera CFO Raffi Asadorian Acquires Common Shares

Maxim Group Remains a Buy on Talphera (TLPH)

Analysts Conflicted on These Healthcare Names: Talphera (TLPH) and Bausch + Lomb Corporation (BLCO)

Talphera Raises $17 Million in Private Placement Led by CorMedix

Talphera Reports Third Quarter 2025 Results and Announces $17 Million Financing

Talphera Inc expected to post a loss of 14 cents a share - Earnings Preview

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/TLPH/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TLPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TLPH\",,,,,undefined,":{"symbol":"TLPH","market":"US","secType":"STK","nameCN":"Talphera Inc.","latestPrice":0.8026,"timestamp":1776456000000,"preClose":0.809,"halted":0,"volume":105261,"hourTrading":{"tag":"盘后","latestPrice":0.8026,"preClose":0.8026,"latestTime":"18:36 EDT","volume":46,"amount":36.35,"timestamp":1776465389303,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.007911001236094032,"floatShares":25153500,"shares":50049799,"eps":-0.336943,"marketStatus":"Market Closed","change":-0.0064,"latestTime":"04-17 16:00:00 EDT","open":0.7923,"high":0.8398,"low":0.79,"amount":85204.69958364,"amplitude":0.061557,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.336943,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1776672000000},"marketStatusCode":7,"adr":0,"listingDate":1297400400000,"exchange":"NASDAQ","adjPreClose":0.809,"preHourTrading":{"tag":"盘前","latestPrice":0.79,"preClose":0.809,"latestTime":"09:25 EDT","volume":101,"amount":79.79,"timestamp":1776432339321,"change":-0.019,"changeRate":-0.023486,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":0.8026,"preClose":0.8026,"latestTime":"18:36 EDT","volume":46,"amount":36.35,"timestamp":1776465389303,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.9779805268735936,"impliedVol":1.408,"impliedVolPercentile":0.452},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TLPH\",,,,,undefined,":{"symbol":"TLPH","floatShares":25153500,"roa":"-35.15%","roe":"-114.74%","lyrEps":-0.338278,"volumeRatio":0.9779805268735936,"shares":50049799,"dividePrice":0,"high":0.8398,"amplitude":0.061557,"preClose":0.809,"low":0.79,"week52Low":0.38,"pbRate":"2.36","psRate":"1434.64","week52High":1.57,"institutionHeld":0,"latestPrice":0.8026,"eps":-0.336943,"divideRate":0,"volume":105261,"delay":0,"ttmEps":-0.336943,"open":0.7923,"prevYearClose":1.14,"prevWeekClose":0.7606,"prevMonthClose":0.7469,"prevQuarterClose":0.7469,"fiveDayClose":0.7606,"twentyDayClose":0.8087,"sixtyDayClose":1},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TLPH\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-23","symbol":"TLPH","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1774238400000,"reportTimeType":"pre","actualEps":-0.06},{"market":"US","date":"2025-11-12","symbol":"TLPH","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-0.11},{"market":"US","date":"2025-08-14","symbol":"TLPH","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"post","actualEps":-0.1},{"market":"US","date":"2025-05-14","symbol":"TLPH","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"post","actualEps":-0.1},{"market":"US","date":"2025-03-31","symbol":"TLPH","fiscalQuarterEnding":"2024/12","expectedEps":-0.21,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"post","actualEps":-0.07}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TLPH\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TLPH\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1715054400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TLPH\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TLPH","date":"2026-04-17","current":-2.382005,"percent":0.231752,"low":-5.813318,"twenty":-3.060026,"median":-1.031561,"eighty":-0.723447,"high":-0.538589,"avg":-1.693967,"sd":1.413683,"marketCap":40490307},"quantilePoints":[{"date":"2024-01-12","current":-0.709783,"twenty":-0.709783,"median":-0.709783,"eighty":-0.709783,"marketCap":15163804},{"date":"2024-01-19","current":-0.768899,"twenty":-0.721606,"median":-0.626863,"eighty":-0.622514,"marketCap":16426748},{"date":"2024-01-26","current":-0.825237,"twenty":-0.834759,"median":-0.716726,"eighty":-0.626609,"marketCap":17630359},{"date":"2024-02-02","current":-0.833172,"twenty":-0.841107,"median":-0.817302,"eighty":-0.683994,"marketCap":17799882},{"date":"2024-02-09","current":-0.682417,"twenty":-0.826824,"median":-0.749854,"eighty":-0.688766,"marketCap":14579166},{"date":"2024-02-16","current":-0.817314,"twenty":-0.826824,"median":-0.768899,"eighty":-0.696692,"marketCap":17461094},{"date":"2024-02-23","current":-1.047431,"twenty":-0.872852,"median":-0.817302,"eighty":-0.705181,"marketCap":22377325},{"date":"2024-03-01","current":-1.079172,"twenty":-0.991886,"median":-0.817314,"eighty":-0.710598,"marketCap":23055425},{"date":"2024-03-08","current":-1.045883,"twenty":-1.042051,"median":-0.825237,"eighty":-0.718658,"marketCap":19241109},{"date":"2024-03-15","current":-1.051518,"twenty":-1.046502,"median":-0.872847,"eighty":-0.724723,"marketCap":19344777},{"date":"2024-03-22","current":-1.03307,"twenty":-1.051518,"median":-0.952196,"eighty":-0.737703,"marketCap":19005395},{"date":"2024-03-28","current":-1.014623,"twenty":-1.051518,"median":-0.991886,"eighty":-0.749061,"marketCap":18666013},{"date":"2024-04-05","current":-1.014623,"twenty":-1.051518,"median":-0.977516,"eighty":-0.759853,"marketCap":18666013},{"date":"2024-04-12","current":-1.051518,"twenty":-1.060742,"median":-0.991886,"eighty":-0.78826,"marketCap":19344777},{"date":"2024-04-19","current":-0.95928,"twenty":-1.057052,"median":-0.989418,"eighty":-0.817302,"marketCap":17647867},{"date":"2024-04-26","current":-1.03307,"twenty":-1.051518,"median":-0.968081,"eighty":-0.817307,"marketCap":19005395},{"date":"2024-05-03","current":-0.942156,"twenty":-1.051518,"median":-0.955738,"eighty":-0.817314,"marketCap":17332836},{"date":"2024-05-10","current":-0.942156,"twenty":-1.051518,"median":-0.951392,"eighty":-0.817314,"marketCap":17332836},{"date":"2024-05-17","current":-1.376289,"twenty":-1.051518,"median":-0.951439,"eighty":-0.820483,"marketCap":19541923},{"date":"2024-05-24","current":-1.244644,"twenty":-1.066276,"median":-0.95928,"eighty":-0.825237,"marketCap":17672696},{"date":"2024-05-31","current":-1.220708,"twenty":-1.07919,"median":-0.968081,"eighty":-0.826824,"marketCap":17332836},{"date":"2024-06-07","current":-1.172597,"twenty":-1.105016,"median":-0.989418,"eighty":-0.838101,"marketCap":16649701},{"date":"2024-06-14","current":-1.172837,"twenty":-1.162665,"median":-0.991886,"eighty":-0.857817,"marketCap":16653117},{"date":"2024-06-21","current":-0.989731,"twenty":-1.167223,"median":-0.991886,"eighty":-0.86955,"marketCap":14053191},{"date":"2024-06-28","current":-1.089063,"twenty":-1.169518,"median":-0.998642,"eighty":-0.872556,"marketCap":15463609},{"date":"2024-07-05","current":-1.101031,"twenty":-1.166458,"median":-1.010011,"eighty":-0.872847,"marketCap":15633538},{"date":"2024-07-12","current":-1.078532,"twenty":-1.162665,"median":-1.014623,"eighty":-0.872847,"marketCap":15314070},{"date":"2024-07-15","current":-1.112999,"twenty":-1.155488,"median":-1.023092,"eighty":-0.872849,"marketCap":15803468},{"date":"2024-08-02","current":-1.11611,"twenty":-1.148312,"median":-1.031561,"eighty":-0.872852,"marketCap":15847650},{"date":"2024-08-09","current":-1.1495,"twenty":-1.140413,"median":-1.03307,"eighty":-0.881601,"marketCap":16321754},{"date":"2024-08-16","current":-1.082672,"twenty":-1.150506,"median":-1.03307,"eighty":-0.89914,"marketCap":14783889},{"date":"2024-08-23","current":-1.12013,"twenty":-1.150506,"median":-1.041541,"eighty":-0.908733,"marketCap":15295378},{"date":"2024-08-30","current":-1.214584,"twenty":-1.160535,"median":-1.047431,"eighty":-0.91316,"marketCap":16585145},{"date":"2024-09-06","current":-1.256895,"twenty":-1.172134,"median":-1.051518,"eighty":-0.91362,"marketCap":17162906},{"date":"2024-09-13","current":-1.120006,"twenty":-1.172789,"median":-1.052339,"eighty":-0.917105,"marketCap":15293679},{"date":"2024-09-20","current":-1.171526,"twenty":-1.172383,"median":-1.060742,"eighty":-0.925267,"marketCap":15997188},{"date":"2024-09-27","current":-1.007507,"twenty":-1.171277,"median":-1.062038,"eighty":-0.931608,"marketCap":13757514},{"date":"2024-10-04","current":-0.983116,"twenty":-1.169518,"median":-1.060742,"eighty":-0.932246,"marketCap":13424451},{"date":"2024-10-11","current":-0.995561,"twenty":-1.165699,"median":-1.055876,"eighty":-0.935347,"marketCap":13594381},{"date":"2024-10-18","current":-1.443563,"twenty":-1.165699,"median":-1.051518,"eighty":-0.938196,"marketCap":19711853},{"date":"2024-10-25","current":-1.193428,"twenty":-1.172383,"median":-1.059667,"eighty":-0.940832,"marketCap":16296264},{"date":"2024-10-31","current":-1.145268,"twenty":-1.175829,"median":-1.062038,"eighty":-0.940832,"marketCap":15638636},{"date":"2024-11-08","current":-1.120006,"twenty":-1.172837,"median":-1.065997,"eighty":-0.942156,"marketCap":15293679},{"date":"2024-11-15","current":-0.718871,"twenty":-1.172597,"median":-1.067654,"eighty":-0.942156,"marketCap":11251050},{"date":"2024-11-22","current":-0.759152,"twenty":-1.171526,"median":-1.065128,"eighty":-0.934799,"marketCap":11881489},{"date":"2024-11-29","current":-0.769204,"twenty":-1.170532,"median":-1.060742,"eighty":-0.922038,"marketCap":12038805},{"date":"2024-12-06","current":-0.744233,"twenty":-1.169884,"median":-1.055876,"eighty":-0.903567,"marketCap":11647985},{"date":"2024-12-13","current":-0.714964,"twenty":-1.167123,"median":-1.051518,"eighty":-0.872774,"marketCap":11189899},{"date":"2024-12-20","current":-0.671877,"twenty":-1.163424,"median":-1.049475,"eighty":-0.831585,"marketCap":10515542},{"date":"2024-12-27","current":-0.54947,"twenty":-1.159469,"median":-1.044734,"eighty":-0.819817,"marketCap":8599755},{"date":"2025-01-03","current":-0.642064,"twenty":-1.157339,"median":-1.038589,"eighty":-0.817307,"marketCap":10048941},{"date":"2025-01-10","current":-0.632054,"twenty":-1.156244,"median":-1.034537,"eighty":-0.816045,"marketCap":9892272},{"date":"2025-01-17","current":-0.674597,"twenty":-1.151726,"median":-1.03307,"eighty":-0.770977,"marketCap":10558115},{"date":"2025-01-24","current":-0.772522,"twenty":-1.151176,"median":-1.031561,"eighty":-0.769204,"marketCap":12090744},{"date":"2025-01-31","current":-0.761424,"twenty":-1.1495,"median":-1.014623,"eighty":-0.766969,"marketCap":11917046},{"date":"2025-02-07","current":-0.750761,"twenty":-1.145268,"median":-1.008005,"eighty":-0.759152,"marketCap":11750160},{"date":"2025-02-14","current":-0.686565,"twenty":-1.145019,"median":-1.005399,"eighty":-0.750761,"marketCap":10745436},{"date":"2025-02-21","current":-0.665892,"twenty":-1.145019,"median":-0.995934,"eighty":-0.743362,"marketCap":10421881},{"date":"2025-02-28","current":-0.62879,"twenty":-1.144322,"median":-0.991886,"eighty":-0.729,"marketCap":9841185},{"date":"2025-03-07","current":-0.555931,"twenty":-1.135885,"median":-0.989659,"eighty":-0.722709,"marketCap":8700874},{"date":"2025-03-14","current":-0.614754,"twenty":-1.13372,"median":-0.983614,"eighty":-0.709274,"marketCap":9621508},{"date":"2025-03-21","current":-0.670245,"twenty":-1.132699,"median":-0.983116,"eighty":-0.695334,"marketCap":10489998},{"date":"2025-03-28","current":-0.674597,"twenty":-1.130559,"median":-0.968503,"eighty":-0.691179,"marketCap":10558115},{"date":"2025-04-04","current":-0.746305,"twenty":-1.128493,"median":-0.963783,"eighty":-0.690853,"marketCap":9704951},{"date":"2025-04-11","current":-0.644804,"twenty":-1.127045,"median":-0.958352,"eighty":-0.685651,"marketCap":8385028},{"date":"2025-04-17","current":-0.606147,"twenty":-1.125692,"median":-0.951485,"eighty":-0.684843,"marketCap":7882337},{"date":"2025-04-25","current":-0.637835,"twenty":-1.122064,"median":-0.950724,"eighty":-0.677643,"marketCap":8294407},{"date":"2025-05-02","current":-0.672679,"twenty":-1.120056,"median":-0.942156,"eighty":-0.674597,"marketCap":8747513},{"date":"2025-05-09","current":-0.724352,"twenty":-1.120006,"median":-0.941494,"eighty":-0.674597,"marketCap":9419478},{"date":"2025-05-16","current":-0.71959,"twenty":-1.120006,"median":-0.937537,"eighty":-0.674597,"marketCap":8378189},{"date":"2025-05-23","current":-0.74015,"twenty":-1.120006,"median":-0.931608,"eighty":-0.674727,"marketCap":8617565},{"date":"2025-05-30","current":-0.719737,"twenty":-1.120006,"median":-0.919571,"eighty":-0.675162,"marketCap":8379898},{"date":"2025-06-06","current":-0.858669,"twenty":-1.120006,"median":-0.91316,"eighty":-0.676271,"marketCap":9997488},{"date":"2025-06-13","current":-0.895475,"twenty":-1.118448,"median":-0.90459,"eighty":-0.677869,"marketCap":10426010},{"date":"2025-06-20","current":-0.857613,"twenty":-1.115488,"median":-0.898204,"eighty":-0.679406,"marketCap":9985186},{"date":"2025-06-27","current":-0.774845,"twenty":-1.112633,"median":-0.894713,"eighty":-0.681471,"marketCap":9021523},{"date":"2025-07-03","current":-0.794216,"twenty":-1.11117,"median":-0.872847,"eighty":-0.682417,"marketCap":9247061},{"date":"2025-07-11","current":-0.899877,"twenty":-1.107561,"median":-0.872847,"eighty":-0.683592,"marketCap":10477269},{"date":"2025-07-18","current":-0.757235,"twenty":-1.107561,"median":-0.872483,"eighty":-0.684381,"marketCap":8816489},{"date":"2025-07-25","current":-0.754241,"twenty":-1.106861,"median":-0.860783,"eighty":-0.685151,"marketCap":8781633},{"date":"2025-08-01","current":-0.736103,"twenty":-1.106861,"median":-0.857817,"eighty":-0.685369,"marketCap":8570447},{"date":"2025-08-08","current":-0.689436,"twenty":-1.106752,"median":-0.851978,"eighty":-0.685477,"marketCap":8027105},{"date":"2025-08-15","current":-0.756531,"twenty":-1.103828,"median":-0.838418,"eighty":-0.685695,"marketCap":8808287},{"date":"2025-08-22","current":-0.883718,"twenty":-1.101031,"median":-0.838112,"eighty":-0.685696,"marketCap":9990428},{"date":"2025-08-29","current":-0.990642,"twenty":-1.101031,"median":-0.847047,"eighty":-0.686565,"marketCap":11199212},{"date":"2025-09-05","current":-0.936182,"twenty":-1.101031,"median":-0.857613,"eighty":-0.688862,"marketCap":10583533},{"date":"2025-09-12","current":-1.807918,"twenty":-1.104413,"median":-0.858405,"eighty":-0.69017,"marketCap":20438512},{"date":"2025-09-19","current":-1.694095,"twenty":-1.107561,"median":-0.864657,"eighty":-0.690543,"marketCap":19151741},{"date":"2025-09-26","current":-3.637584,"twenty":-1.116889,"median":-0.872847,"eighty":-0.690853,"marketCap":41122885},{"date":"2025-10-03","current":-3.795249,"twenty":-1.120006,"median":-0.883718,"eighty":-0.691179,"marketCap":42905287},{"date":"2025-10-10","current":-5.121086,"twenty":-1.125329,"median":-0.890989,"eighty":-0.691911,"marketCap":57893874},{"date":"2025-10-17","current":-4.677527,"twenty":-1.132699,"median":-0.895475,"eighty":-0.69366,"marketCap":52879444},{"date":"2025-10-24","current":-4.59688,"twenty":-1.145019,"median":-0.899085,"eighty":-0.695114,"marketCap":51967729},{"date":"2025-10-31","current":-5.000115,"twenty":-1.151314,"median":-0.905781,"eighty":-0.696075,"marketCap":56526302},{"date":"2025-11-07","current":-4.782588,"twenty":-1.163424,"median":-0.91316,"eighty":-0.696335,"marketCap":54067156},{"date":"2025-11-14","current":-4.329067,"twenty":-1.17174,"median":-0.915726,"eighty":-0.697893,"marketCap":48940098},{"date":"2025-11-21","current":-4.92885,"twenty":-1.176428,"median":-0.931608,"eighty":-0.699963,"marketCap":61058599},{"date":"2025-11-28","current":-5.0041,"twenty":-1.189064,"median":-0.935491,"eighty":-0.701687,"marketCap":61990791},{"date":"2025-12-05","current":-4.740726,"twenty":-1.200767,"median":-0.940832,"eighty":-0.703011,"marketCap":58728118},{"date":"2025-12-12","current":-4.477353,"twenty":-1.212531,"median":-0.942156,"eighty":-0.703969,"marketCap":55465445},{"date":"2025-12-19","current":-4.176354,"twenty":-1.232226,"median":-0.942156,"eighty":-0.706105,"marketCap":51736675},{"date":"2025-12-26","current":-4.251604,"twenty":-1.232676,"median":-0.951392,"eighty":-0.707239,"marketCap":52668868},{"date":"2026-01-02","current":-4.289229,"twenty":-1.242096,"median":-0.951485,"eighty":-0.707517,"marketCap":53134964},{"date":"2026-01-09","current":-4.101105,"twenty":-1.256838,"median":-0.958816,"eighty":-0.708842,"marketCap":50804483},{"date":"2026-01-16","current":-3.734263,"twenty":-1.293886,"median":-0.966938,"eighty":-0.709707,"marketCap":46260045},{"date":"2026-01-23","current":-3.800106,"twenty":-1.368896,"median":-0.968503,"eighty":-0.709783,"marketCap":47075714},{"date":"2026-01-30","current":-3.664657,"twenty":-1.486781,"median":-0.981202,"eighty":-0.709889,"marketCap":45397767},{"date":"2026-02-06","current":-2.968221,"twenty":-1.680116,"median":-0.983116,"eighty":-0.709889,"marketCap":36770327},{"date":"2026-02-13","current":-3.056263,"twenty":-1.706439,"median":-0.983407,"eighty":-0.711142,"marketCap":37860992},{"date":"2026-02-20","current":-3.039709,"twenty":-2.039979,"median":-0.987254,"eighty":-0.7142,"marketCap":37655910},{"date":"2026-02-27","current":-3.479919,"twenty":-3.006599,"median":-0.989731,"eighty":-0.716269,"marketCap":43109235},{"date":"2026-03-06","current":-3.291419,"twenty":-3.056564,"median":-0.991886,"eighty":-0.718416,"marketCap":40774093},{"date":"2026-03-13","current":-3.048362,"twenty":-3.135276,"median":-0.995561,"eighty":-0.719446,"marketCap":37763112},{"date":"2026-03-20","current":-3.084494,"twenty":-3.135276,"median":-1.001197,"eighty":-0.719708,"marketCap":38210710},{"date":"2026-03-27","current":-2.705983,"twenty":-3.135276,"median":-1.007507,"eighty":-0.720855,"marketCap":38668494},{"date":"2026-04-02","current":-2.723845,"twenty":-3.103753,"median":-1.00807,"eighty":-0.721557,"marketCap":38923748},{"date":"2026-04-10","current":-2.844679,"twenty":-3.071845,"median":-1.014623,"eighty":-0.722605,"marketCap":40650467},{"date":"2026-04-17","current":-2.833471,"twenty":-3.060026,"median":-1.031561,"eighty":-0.723447,"marketCap":40490307}],"updateTime":1776598034469},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TLPH\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2622025883","title":"Talphera CEO Vincent J. Angotti acquires 213,310 common shares; value rises to $125,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2622025883","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622025883?lang=en_us&edition=fundamental","pubTime":"2026-03-26 07:58","pubTimestamp":1774483104,"startTime":"0","endTime":"0","summary":"Talphera reported that Chief Executive Officer and director Vincent Angotti acquired 213,310 shares of common stock.The shares were purchased at a price of USD 0.59 per share.Following the transaction, Vincent Angotti beneficially owned 800,705 shares of Talphera common stock.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Talphera Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 25, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDL2Tqrlv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Talphera CEO Vincent J. Angotti acquires 213,310 common shares; value rises to $125,000","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TLPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622207512","title":"Talphera announces two abstracts accepted for AKI & CRRT 2026; NEPHRO-CRRT nafamostat registrational study enrolls patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2622207512","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622207512?lang=en_us&edition=fundamental","pubTime":"2026-03-25 20:31","pubTimestamp":1774441879,"startTime":"0","endTime":"0","summary":"Talphera said two abstracts were accepted for poster presentation at the AKI & CRRT 2026 conference in San Diego, with presentations scheduled for March 29 and March 30.One poster will outline the NEPHRO-CRRT randomized, placebo-controlled, multi-center registrational study design evaluating Niyad in patients undergoing continuous renal replacement therapy who cannot tolerate heparin or are at higher risk of bleeding, and noted the study is currently enrolling patients.A second poster will present in vivo data from a porcine model of AKI receiving CRRT, reporting that over 95% of nafamostat was removed by the hemofilter and that median systemic exposures were less than 5% of the pre-filter exposure.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or leg","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDL2Kn0f2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLPH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621060621","title":"Analysts Offer Insights on Healthcare Companies: Fennec Pharmaceuticals (FENC), Talphera (TLPH) and Abivax SA Sponsored ADR (ABVX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2621060621","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621060621?lang=en_us&edition=fundamental","pubTime":"2026-03-24 21:10","pubTimestamp":1774357821,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Fennec Pharmaceuticals (FENC), Talphera (TLPH) and A...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-fennec-pharmaceuticals-fenc-talphera-tlph-and-abivax-sa-sponsored-adr-abvx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-fennec-pharmaceuticals-fenc-talphera-tlph-and-abivax-sa-sponsored-adr-abvx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4137","XBI","ABVX","HCSG","BK4139","BK4581","LABU","LU0029874061.USD","LU0128526141.USD","TLPH","XLV","AAVXF","FENC","BK4007","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621770529","title":"Talphera Q4 EPS $(0.06) Beats $(0.14) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2621770529","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621770529?lang=en_us&edition=fundamental","pubTime":"2026-03-23 20:43","pubTimestamp":1774269785,"startTime":"0","endTime":"0","summary":"Talphera (NASDAQ:TLPH) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.14) by 57.14 percent. This is a 14.29 percent increase over losses of $(0.07) per share from the same","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/51403363/talphera-q4-eps-0-06-beats-0-14-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TLPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621705515","title":"Talphera Q4 net loss widens 101.71% to USD 3.8 million on cash and investments of USD 20 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2621705515","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621705515?lang=en_us&edition=fundamental","pubTime":"2026-03-23 20:32","pubTimestamp":1774269163,"startTime":"0","endTime":"0","summary":"Talphera published a press release reporting fourth-quarter and full-year 2025 financial results and a corporate update.Fourth-quarter net loss attributable to common shareholders was USD 3.8 million, widening 103.2% year over year.Combined R&D and SG&A expenses in the fourth quarter were USD 3.5 million, up 16.7%, driven primarily by higher costs tied to Niyad development and certain G&A expenses.Cash and investments totaled USD 20.4 million at Dec. 31, 2025, and Talphera said it closed a USD 4.1 million financing tranche after reaching 50% enrollment  in the NEPHRO CRRT study.For 2026, cash operating expenses excluding stock-based compensation are expected to be USD 17.0 million to USD 18.0 million, reflecting costs to finalize the NEPHRO CRRT registration trial and related CMC expenses and validation batches ahead of a planned FDA PMA filing.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nNDL39fFD9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TLPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621705982","title":"Talphera Inc - Expects 2026 Cash Operating Expenses Excluding Stock-Based Compensation of $17 Mln-$18 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2621705982","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621705982?lang=en_us&edition=fundamental","pubTime":"2026-03-23 20:30","pubTimestamp":1774269002,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nTUABDX38D:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TLPH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621705317","title":"Talphera, Inc Q4 Net Income From Cont Ops USD -3.772 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2621705317","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621705317?lang=en_us&edition=fundamental","pubTime":"2026-03-23 20:30","pubTimestamp":1774269001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nPLXA20E44:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TLPH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621589705","title":"Press Release: Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2621589705","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621589705?lang=en_us&edition=fundamental","pubTime":"2026-03-23 20:30","pubTimestamp":1774269000,"startTime":"0","endTime":"0","summary":"Previously announced achievement of 50% enrollment of the NEPHRO CRRT clinical study in March 2026 and closed the associated financing tranche of $4.1 million. All 12 clinical study sites now able to enroll patients to support an expected study completion in 2026. Cash and investments of $20.4 million at December 31, 2025. Virtual investor and analyst day with business updates to be held on Monday, March 23, 2026 at 11:00 am ET. SAN MATEO, Calif., March 23, 2026 /PRNewswire/ -- Talphera, Inc. , , a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced fourth quarter and full year 2025 financial results and provided a corporate update.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","IDE","ARDS","BK4022","R","BK4007","BK4139","TLPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620264762","title":"Talphera to host virtual investor and analyst event on Niyad for CRRT","url":"https://stock-news.laohu8.com/highlight/detail?id=2620264762","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620264762?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:07","pubTimestamp":1773864429,"startTime":"0","endTime":"0","summary":"Talphera will host a virtual investor and analyst event on March 23, 2026 at 11:00 AM ET to discuss Niyad for use in continuous renal replacement therapy . The event will feature Blaithin McMahon and Joao Teixeira, principal investigators in the NEPHRO CRRT study. Registration is available at .","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDLCCzGF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TLPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619253468","title":"Talphera sells 639,931 shares in private placement for USD 4.1 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2619253468","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619253468?lang=en_us&edition=fundamental","pubTime":"2026-03-16 20:33","pubTimestamp":1773664385,"startTime":"0","endTime":"0","summary":"Talphera reported a third closing of its private placement on March 13, 2026, issuing 639,931 common shares at USD 0.586 per share. The company also issued pre-funded warrants priced at USD 0.585 to purchase up to 6.4 million common shares, with an exercise price of USD 0.001 per share. Talphera said gross proceeds from the third closing were about USD 4.1 million, excluding any proceeds from warrant exercises. The securities were sold in a private placement under Section 4 and Regulation D and were not registered under the Securities Act.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Talphera Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system o","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nNDL3SK6WQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TLPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619611094","title":"Nasdaq flags Talphera bid-price noncompliance risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2619611094","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619611094?lang=en_us&edition=fundamental","pubTime":"2026-03-14 04:06","pubTimestamp":1773432389,"startTime":"0","endTime":"0","summary":"Talphera Inc. said it received a notice from Nasdaq that it is not in compliance with the exchange’s $1.00 minimum bid price requirement for continued listing on the Nasdaq Capital Market. The company has 180 days, until Sept. 7, 2026, to regain compliance by maintaining a closing bid price of at least $1.00 for at least 10 consecutive business days, and may be able to seek an additional 180-day cure period if it meets other listing standards. Talphera said the notice does not immediately affect its listing and that it is monitoring its share price and evaluating options to regain compliance.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Talphera Inc. published the original content used to generate this news brief via EDGAR, the Elect","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nNDL7m2dRp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TLPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616378136","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: CalciMedica (CALC) and Talphera (TLPH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2616378136","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616378136?lang=en_us&edition=fundamental","pubTime":"2026-03-04 01:40","pubTimestamp":1772559608,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on CalciMedica (CALC – Research Report) and Talphera (TLPH – Researc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-calcimedica-calc-and-talphera-tlph-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-calcimedica-calc-and-talphera-tlph-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4581","XLV","LU0128526141.USD","BK4137","CALC","HCSG","LU0029874061.USD","BK4007","LABU","TLPH","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616337050","title":"Talphera to Host Virtual Investor and Analyst Event at 11:00 a.m. ET","url":"https://stock-news.laohu8.com/highlight/detail?id=2616337050","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616337050?lang=en_us&edition=fundamental","pubTime":"2026-03-02 21:31","pubTimestamp":1772458280,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Talphera Inc. published the original content used to generate this news brief via PR Newswire  on March 02, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nNDL5vwsng:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TLPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616337014","title":"BRIEF-Talphera Announces 50% Enrollment Milestone In Ongoing Nephro-Crrt Registrational Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2616337014","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616337014?lang=en_us&edition=fundamental","pubTime":"2026-03-02 21:31","pubTimestamp":1772458274,"startTime":"0","endTime":"0","summary":"BRIEF-Talphera Announces 50% Enrollment Milestone In Ongoing Nephro-Crrt Registrational TrialMarch 2 (Reuters) - Talphera Inc TLPH.O:TALPHERA ANNOUNCES 50% ENROLLMENT MILESTONE IN ONGOING NEPHRO-CRRT ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nTUA6WFGCG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLPH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613216569","title":"Talphera CFO Raffi Asadorian Acquires Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2613216569","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613216569?lang=en_us&edition=fundamental","pubTime":"2026-02-21 09:23","pubTimestamp":1771637037,"startTime":"0","endTime":"0","summary":"Raffi Asadorian, Chief Financial Officer of Talphera Inc., reported an acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Talphera Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 20, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260221:nNDLb9bfNM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Talphera CFO Raffi Asadorian Acquires Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLPH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2583073275","title":"Maxim Group Remains a Buy on Talphera (TLPH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2583073275","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583073275?lang=en_us&edition=fundamental","pubTime":"2025-11-14 22:55","pubTimestamp":1763132115,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Naz Rahman from Maxim Group reiterated a Buy rating on Talphera, with a price target of $3.00. Rahman covers the He...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/maxim-group-remains-a-buy-on-talphera-tlph-blurbs-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/maxim-group-remains-a-buy-on-talphera-tlph-blurbs-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLPH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2583054895","title":"Analysts Conflicted on These Healthcare Names: Talphera (TLPH) and Bausch + Lomb Corporation (BLCO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2583054895","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583054895?lang=en_us&edition=fundamental","pubTime":"2025-11-14 20:30","pubTimestamp":1763123420,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Talphera (TLPH – Research Report) and Bausch + Lomb Corporation (...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-talphera-tlph-and-bausch-lomb-corporation-blco-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-talphera-tlph-and-bausch-lomb-corporation-blco-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BLCO","BK4198","BK4007","BK4588","LU0029874061.USD","BK4585","LU0128526141.USD","BK4137","BK4581","XBI","LABU","XLV","HCSG","TLPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2583045588","title":"Talphera Raises $17 Million in Private Placement Led by CorMedix","url":"https://stock-news.laohu8.com/highlight/detail?id=2583045588","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583045588?lang=en_us&edition=fundamental","pubTime":"2025-11-13 05:15","pubTimestamp":1762982107,"startTime":"0","endTime":"0","summary":"Talphera Inc. has announced the closing of the first tranche of a private placement financing, raising $17 million as part of a two-tranche deal for up to $29 million. The financing round was led by CorMedix, Inc. and included participation from existing investors Nantahala Capital, Rosalind Advisors, Rock Springs Capital, as well as new institutional investors. The second tranche is contingent on Talphera's stock price reaching or exceeding $0.6875 for five consecutive days following the achievement of the primary endpoint in the NEPHRO CRRT study, though investors may waive this condition. In addition, certain purchasers have already waived conditions to enable further closings, resulting in additional gross proceeds of approximately $1.6 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDL8dNj71:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLPH","CRMD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2583203588","title":"Talphera Reports Third Quarter 2025 Results and Announces $17 Million Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2583203588","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583203588?lang=en_us&edition=fundamental","pubTime":"2025-11-13 05:09","pubTimestamp":1762981795,"startTime":"0","endTime":"0","summary":"Talphera Inc. announced its third quarter 2025 financial results and provided a corporate update. As of September 30, 2025, the company reported cash and investments totaling $21.3 million. In September, Talphera closed the first tranche of a two-part private placement financing, raising $17 million, with a second tranche of up to $12 million pending based on certain stock price and clinical study milestones. The financing was led by CorMedix, Inc. and included participation from existing and new institutional investors. Talphera stated it expects its current cash position, together with future financing tranches, to be sufficient through a potential PMA approval of Niyad in late 2026. The company also announced that five of nine target profile clinical study sites for the NEPHRO study are now activated, with study completion expected in the first half of 2026. Four additional sites are expected to be activated in the fourth quarter of 2025.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDL1gNfB7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLPH","CRMD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2579463854","title":"Talphera Inc  expected to post a loss of 14 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2579463854","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579463854?lang=en_us&edition=fundamental","pubTime":"2025-10-31 19:02","pubTimestamp":1761908524,"startTime":"0","endTime":"0","summary":"Talphera Inc  expected to post a loss of14cents a share - Earnings Preview Talphera Inc TLPH.OQ TLPH.O is expected to  show no change in quarterly revenue when it reports  results on November 4 (estim","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251031:nL8N3WC0XY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TLPH"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":25,"code":"91000000","status":"200"}]}}